Back to GOLDMAN SACHS GROUP INC GOLDMAN SACHS GROUP INC

ALLOALLO
7 quarters

Position history for GOLDMAN SACHS GROUP INCGOLDMAN SACHS GROUP INC's holdings in ALLOGENE THERAPEUTICS INC

GOLDMAN SACHS GROUP INC holds 6.1M shares of ALLO (ALLOGENE THERAPEUTICS INC), worth $12.8M as of 2026-Q2. The position was increased (+122.3% shares). ALLO represents 0.0% of GOLDMAN SACHS GROUP INC's portfolio.

Current Value

$12.8M

Current Shares

6.1M

Total Value Change

+$8.3M

Total Shares Change

+4M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
6.1M
+122.3%
$12.8M0.0%$2.08
45
2026-Q1
Increased
2.8M
+20.8%
$6.7M0.0%$2.53
33
2025-Q4
Increased
2.3M
+90.2%
$3.1M0.0%$1.31
42
2025-Q3
Decreased
1.2M
-78.1%
$1.5M0.0%$1.27
0
2025-Q2
Decreased
5.5M
-6.0%
$6.2M0.0%$1.18
0
2025-Q1
Increased
5.9M
+177.9%
$8.5M0.0%$1.55
44
2024-Q4
New
2.1M
-
$4.5M0.0%$2.10
37

Other major holders of ALLO: TPG Group Holdings (SBS) Advisors, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used